Health & Biotech
Health & Biotech
Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed
Health & Biotech
New breakthrough in stem cells research paves the way for ASX regenerative medicine stocks
Health & Biotech
Intelicare flags major traction from recent marketing drive as brand awareness rises sharply
Tech
Health Kick: New ASX listee Audeara uses algorithms to create perfect audio and better hearing health
Health & Biotech
Creso Pharma’s takeover target expands scope of PTSD ‘shroom’ trial beyond military vets
Health & Biotech
FDA’s landmark approval of Biogen’s Alzheimer’s drug sends Cogstate up 60 per cent
Health & Biotech
Executive insights: How Apiam is capitalising on the major opportunity in ‘greenfield’ vet clinics
Health & Biotech
Dimerix secures ILAP approval in the UK as it builds momentum with global health regulators
Health & Biotech
Creso Pharma sells hemp products in Ecuador, gears up for the lucrative Latin American market
Health & Biotech
Dr Boreham’s Crucible: Is Universal Biosensors really the ‘Tesla or Apple’ of handheld detection?
Health & Biotech
As medicinal cannabis rockets globally, here’s how Australia can become a production powerhouse
Health & Biotech
Exopharm takes major step forward in global strategy with approval for its first national patent
Health & Biotech
Weed Week: Major shifts in US legislation set to open the door for some ASX cannabis stocks
Health & Biotech
Dimerix gets go-ahead from European regulators in key step towards Phase 3 trials for FSGS kidney treatment
Health & Biotech
Creso Pharma about to enter California market after major legislation shift on psychedelics
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.